Home
Conditions
Leiomyosarcoma

Clinical trial condition

Leiomyosarcoma

Explore clinical trials studying Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

57 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Leiomyosarcoma trial results

Recruiting

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

NCT03016819

Conditions: Alveolar Soft Part Sarcoma, Leiomyosarcoma, Neoplasms, +9 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

University of California Los Angeles Los Angeles, California, United States

Sarcoma Oncology Center Santa Monica, California, United States

Stanford Medicine Cancer Institute Stanford, California, United States

View all 24 locations

View Trial Details

Recruiting

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

NCT04055220

Conditions: Angiosarcoma, Behavior, Bone Diseases, +31 more
Locations: Hôpital Jean Minjoz Besançon, France

Institut Bergonié Bordeaux, France

Centre Oscar Lambret Lille, France

Centre Léon Bérard Lyon, France

View all 16 locations

View Trial Details

Recruiting

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

NCT07169344

Conditions: Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +19 more
Locations: Haukeland University Hospital Bergen, Norway

Oslo University Hospital Oslo, Norway

University Hospital of North Norway Tromsø, Norway

St. Olavs University Hospital Trondheim, Norway

View Trial Details

Recruiting

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

NCT06849986

Conditions: Angiosarcoma, Desmoplastic Small Round Cell Tumor, Fibrosarcoma, +24 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

NCT06528769

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

NCT06277154

Conditions: Angiosarcoma, Desmoplastic Small Round Cell Tumor, Endometrial Neoplasms, +43 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Recruiting

Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients

NCT06875700

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT01793168

Conditions: 1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V, 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome, +698 more
Locations: Sanford Health Sioux Falls, South Dakota, United States

Online Patient Enrollment System Sydney, Australia

View Trial Details

Recruiting

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

NCT04535271

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: Sant P Chawla Santa Monica, California, United States

View Trial Details

Recruiting

Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

NCT02275286

Conditions: Leiomyosarcoma, Liposarcoma, Liposarcoma, Myxoid, +8 more
Locations: Institut Bergonié Bordeaux, France

Centre Léon Berard Lyon, France

Istituto Clinico Humanitas Rozzano, Milan, Italy

Centro di Referimento Ocologico Aviano, Italy

View all 17 locations

View Trial Details

Leiomyosarcoma

Leiomyosarcoma trial results

Related conditions